
Bacteriostatic Water
Sterile reconstitution diluent, 3ml
From
£4

FORM Peptides clear glass vial, research use only.
For research use only. Not for human consumption.
≥98% HPLC · Lyophilised vial
Dual GIP/GLP-1 agonist referenced in incretin-pathway research.
Tirzepatide is a dual agonist targeting both the GIP and GLP-1 receptors, two hormones released after eating that regulate appetite, insulin response, and fat storage. By activating both simultaneously, it produces a more pronounced effect on appetite reduction and blood sugar control than single-receptor compounds, which is reflected in the clinical trial data supporting its approval as Mounjaro in both the US and UK. It represents the current leading edge of approved receptor-based weight management and type 2 diabetes treatment.
Format & strength
Pen
£185
/ vialDocuments
Reconstituting research material? An interactive vial draw calculator is available for dilution and volume equivalence.
Using the multi-use pen format? A pen draw calculator covers U-100 volume equivalence.
Complete your order by email or WhatsApp and our team will respond with payment and dispatch confirmation. We accept bank transfer and cryptocurrency, with card checkout coming soon. Reach us at info@formpeptides.co.uk or via WhatsApp.
Specification
Related compounds

Sterile reconstitution diluent, 3ml
From
£4

Modified GH fragment, 5mg vial
From
£30

Triple GIP/GLP-1/glucagon agonist, 50mg vial
From
£155
Product FAQ
Programmatic supply
Bulk and recurring research supply, custom batch documentation, and institutional invoicing are available on request.
Supplied for research purposes only. Not for human consumption. FORM Peptides does not provide dosage or consumption advice.